🇮🇳 India starts human trials for a new indigenous vaccine
09 February 2026
by admin
(0) Comments
🇮🇳 India starts human trials for a new indigenous vaccine
India has begun Phase-1 human trialsof a locally developed vaccine for Kyasanur Forest Disease (a deadly tick-borne viral infection affecting Western Ghats regions).
Why this matters: The next decade of medicine will be research-driven — AI biology + precision drugs.
Healthcare is no longer evolving… it’s transforming.
Today’s signals from the industry: • India begins human trials of an indigenous vaccine • Breakthrough pancreatic cancer research emerges • Obesity drugs enter a global price & safety war • Pharma supply chains turn geopolitical • Big pharma doubles down on advanced research
The shift is clear → Healthcare is moving from treatment to long-term disease management ecosystems.
If you work in hospitals, pharma, diagnostics or health tech — these changes will affect your strategy sooner than you think.
Leave a Comment